What's New on the FDA Drugs Site
April 27, 2016
- Drugs@FDA Data Files (updated)
- FDA announced that a safety review has found type 2 diabetes medicines containing saxagliptin and alogliptin may increase the risk of heart failure
- Medication Guide page Updated: Xtampza ER
- FDA Drug Shortages
- Cefazolin Injection (Updated - Currently in Shortage)
- Fresenius Kabi Issues Voluntary Nationwide Recall of Sensorcaine-MPF (bupivacaine HCl) Injection, USP due to the Presence of Particulate Matter Characterized as Glass
- GDUFA Reauthorization Stakeholder Meetings (updated)
- Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act (updated)
.png)
No hay comentarios:
Publicar un comentario